e.g. Tata motors, Reliance MF, 500570

Oxygenta Pharmaceutical Ltd. - Research Center

524636 OXYGENTAPH Group (X) BSE data
 
Back to Company Page
Statement:

Balance sheet

(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Sources of funds
Owner's fund
Equity share capital 33.48 14.20 14.20 10.20 10.20
Share application money 0.56 - - - -
Preference share capital - - - - -
Reserves & surplus -54.17 -60.40 -48.83 -48.22 -51.15
Loan funds
Secured loans 57.23 67.99 52.13 2.85 1.00
Unsecured loans - - - 45.04 24.94
Total 37.11 21.79 17.50 9.87 -15.01
Uses of funds
Fixed assets
Gross block 50.53 46.43 36.44 31.18 25.10
Less : revaluation reserve - - - - -
Less : accumulated depreciation 21.18 18.52 16.46 14.87 13.68
Net block 29.36 27.91 19.98 16.31 11.42
Capital work-in-progress - - 0.34 0.65 -
Investments 0.05 0.05 0.05 0.05 0.05
Net current assets
Current assets, loans & advances 33.78 26.30 10.81 16.85 7.15
Less : current liabilities & provisions 26.08 32.47 13.68 24.00 33.63
Total net current assets 7.70 -6.17 -2.87 -7.15 -26.48
Miscellaneous expenses not written - - - - -
Total 37.11 21.79 17.50 9.87 -15.01
Notes:
Book value of unquoted investments 0.05 0.05 0.05 - -
Market value of quoted investments - - - - -
Contingent liabilities - - 1.20 1.20 1.20
Number of equity sharesoutstanding (Lacs) 334.84 142.01 142.01 102.01 102.01
Close
Add Oxygenta Pharmaceutical Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Oxygenta Pharmaceutical Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close